Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 394

Similar articles for PubMed (Select 12846976)

1.

The cast of molecular characters in Parkinson's disease: felons, conspirators, and suspects.

Lim KL, Dawson VL, Dawson TM.

Ann N Y Acad Sci. 2003 Jun;991:80-92. Review.

PMID:
12846976
2.

Ubiquitin-proteasome system and Parkinson's diseases.

Betarbet R, Sherer TB, Greenamyre JT.

Exp Neurol. 2005 Feb;191 Suppl 1:S17-27. Review.

PMID:
15629758
3.

Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.

Shimura H, Schlossmacher MG, Hattori N, Frosch MP, Trockenbacher A, Schneider R, Mizuno Y, Kosik KS, Selkoe DJ.

Science. 2001 Jul 13;293(5528):263-9. Epub 2001 Jun 28.

4.

Genetics of Parkinson's disease and biochemical studies of implicated gene products.

Lansbury PT Jr, Brice A.

Curr Opin Genet Dev. 2002 Jun;12(3):299-306. Review.

PMID:
12076673
5.

Parkin and defective ubiquitination in Parkinson's disease.

Dawson TM.

J Neural Transm Suppl. 2006;(70):209-13. Review.

PMID:
17017531
6.

Recent advances in the genetics and pathogenesis of Parkinson disease.

Mouradian MM.

Neurology. 2002 Jan 22;58(2):179-85. Review.

PMID:
11805242
7.

Genetics of Parkinson's disease.

Gasser T.

J Neurol. 2001 Oct;248(10):833-40. Review.

PMID:
11697518
8.

Genetics of Parkinson's disease and biochemical studies of implicated gene products.

Lansbury PT Jr, Brice A.

Curr Opin Cell Biol. 2002 Oct;14(5):653-60. Review.

PMID:
12231362
9.

Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease.

Chung KK, Zhang Y, Lim KL, Tanaka Y, Huang H, Gao J, Ross CA, Dawson VL, Dawson TM.

Nat Med. 2001 Oct;7(10):1144-50.

PMID:
11590439
10.

Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease.

McNaught KS, Olanow CW.

Ann Neurol. 2003;53 Suppl 3:S73-84; discussion S84-6. Review.

PMID:
12666100
11.

New insights into Parkinson's disease.

Chung KK, Dawson VL, Dawson TM.

J Neurol. 2003 Oct;250 Suppl 3:III15-24. Review.

PMID:
14579120
12.

Importance of familial Parkinson's disease and parkinsonism to the understanding of nigral degeneration in sporadic Parkinson's disease.

Hattori N, Shimura H, Kubo S, Wang M, Shimizu N, Tanaka K, Mizuno Y.

J Neural Transm Suppl. 2000;(60):101-16. Review.

PMID:
11205133
13.

Complex interactions in Parkinson's disease: a two-phased approach.

Maraganore DM, de Andrade M, Lesnick TG, Farrer MJ, Bower JH, Hardy JA, Rocca WA.

Mov Disord. 2003 Jun;18(6):631-6.

PMID:
12784265
14.

Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation.

Lim KL, Chew KC, Tan JM, Wang C, Chung KK, Zhang Y, Tanaka Y, Smith W, Engelender S, Ross CA, Dawson VL, Dawson TM.

J Neurosci. 2005 Feb 23;25(8):2002-9.

15.

Pathological proteins in Parkinson's disease: focus on the proteasome.

Snyder H, Wolozin B.

J Mol Neurosci. 2004;24(3):425-42. Review.

PMID:
15655264
16.

[Parkinson's disease: what have we learned from the genes responsible for familial forms?].

Corti O, Brice A.

Med Sci (Paris). 2003 May;19(5):613-9. Review. French.

17.
18.

Parkinson's disease: one biochemical pathway to fit all genes?

Kr├╝ger R, Eberhardt O, Riess O, Schulz JB.

Trends Mol Med. 2002 May;8(5):236-40. Review.

PMID:
12067634
19.

[Parkin, alpha-synuclein and other molecular aspects of Parkinson's disease].

Corti O, Brice A.

J Soc Biol. 2002;196(1):95-10. Review. French.

PMID:
12134640
20.

UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.

Ardley HC, Scott GB, Rose SA, Tan NG, Robinson PA.

J Neurochem. 2004 Jul;90(2):379-91.

PMID:
15228595
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk